(Press-News.org) ROCHESTER, Minn. — Mayo Clinic researchers have developed a new tool that can estimate a person's risk of developing memory and thinking problems associated with Alzheimer's disease years before symptoms appear. The research, published in The Lancet Neurology, builds on decades of data from the Mayo Clinic Study of Aging — one of the world's most comprehensive population-based studies of brain health.
The study found that women have a higher lifetime risk than men of developing dementia and mild cognitive impairment (MCI), a transitional stage between healthy aging and dementia that often affects quality of life but still allows people to live independently. Men and women with the common genetic variant, APOE ε4, also have higher lifetime risk.
Predicting Alzheimer's disease
Alzheimer's disease is marked by two key proteins in the brain: amyloid, which forms plaques, and tau, which forms tangles. Drugs recently approved by the Food and Drug Administration remove amyloid from the brain and can slow the rate of disease progression for people with MCI or mild dementia.
"What's exciting now is that we're looking even earlier — before symptoms begin — to see if we can predict who might be at greatest risk of developing cognitive problems in the future," says Clifford Jack, Jr., M.D., radiologist and lead author of the study.
The new prediction model combined several factors, including age, sex, genetic risk as associated with APOE genotype and brain amyloid levels detected on PET scans. Using the data, researchers can calculate an individual's likelihood of developing MCI or dementia within 10 years or over the predicted lifetime. Of all the predictors evaluated, the brain amyloid levels detected on PET scans was the predictor with the largest effect for lifetime risk of both MCI and dementia.
"This kind of risk estimate could eventually help people and their doctors decide when to begin therapy or make lifestyle changes that may delay the onset of symptoms. It's similar to how cholesterol levels help predict heart attack risk," says Ronald Petersen, M.D., Ph.D., neurologist and director of the Mayo Clinic Study of Aging, who is a co-author of the study.
The research stands apart because it draws from the Mayo Clinic Study of Aging, a long-running effort in Olmsted County, Minnesota, that tracks thousands of residents over time. The analysis for this study included data from 5,858 participants. Unlike most studies, Mayo researchers are able to continue following participants even after they stop actively taking part, using medical record data — ensuring nearly complete information about who develops cognitive decline or dementia.
"This gives us a uniquely accurate picture of how Alzheimer's unfolds in the community," says Terry Therneau, Ph.D., who led the statistical analysis and is the senior author of the study. "We found that the incident rate of dementia was two times greater among the people who dropped out of the study than those who continued to participate."
The study elevates the significance of MCI, which is the stage targeted by current Alzheimer's drugs that slow but do not stop progression.
While the new tool is currently a research instrument, it represents a major step toward more personalized care. Future versions may incorporate blood-based biomarkers, which could make testing more accessible.
The work was supported by the National Institute on Aging, the GHR Foundation, Gates Ventures and the Alexander Family Foundation.
The research is part of a larger effort at Mayo Clinic called the Precure initiative focused on developing tools that empower clinicians to predict and intercept biological processes before they evolve into disease or progress into complex, hard-to-treat conditions.
"Ultimately, our goal is to give people more time — time to plan, to act and to live well before memory problems take hold," says Dr. Petersen.
Review the study for a complete list of authors, disclosures and funding.
###
About Mayo Clinic
Mayo Clinic is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the Mayo Clinic News Network for additional Mayo Clinic news.
END
Mayo Clinic scientists create tool to predict Alzheimer's risk years before symptoms begin
2025-11-13
ELSE PRESS RELEASES FROM THIS DATE:
Extending anti-clotting treatment linked to lower rates of new clots
2025-11-13
Extending anti-clotting drugs beyond the initial treatment period of at least 90 days after a first blood clot is linked to lower rates of new clots developing compared with stopping treatment, finds a US study published by The BMJ today.
Extended treatment was also linked to higher rates of major bleeding (a common side effect of anti-clotting drugs) but the authors say continued use results in an overall “net clinical benefit.”
Guidelines recommend anti-clotting treatment for at least 3-6 months for patients with venous thromboembolism ...
E-cigarettes compromise children’s human rights
2025-11-13
Exposing children to e-cigarettes compromises their human rights. These products should be regulated in a way that puts children’s best interests first and protects them from the harms associated with nicotine consumption in all its forms, argue experts in The BMJ today.
Children are now using e-cigarettes at higher rates than adults, write Tom Gatehouse and colleagues. Globally, the World Health Organization (WHO) estimates that 7.2% of children aged 13-15 currently use e-cigarettes. Data indicate use in this group is nine times that of adults, in countries which monitor both groups.
As ...
The Lancet Child & Adolescent Health: High blood pressure in children and adolescents nearly doubled between 2000 and 2020, suggests largest global study to date
2025-11-13
The rate of high blood pressure (hypertension) in children and adolescents under 19 has nearly doubled, increasing from about 3% in 2000 to over 6% in 2020.
More than 9% of children and adolescents have masked hypertension — high blood pressure that only shows up with out-of-office tests, meaning hypertension could be undetected during regular checkups.
Nearly 19% of children and adolescents with obesity have hypertension, eight times higher than the prevalence of hypertension in those considered a healthy weight.
Approximately 8% of children and adolescents now have prehypertension, a warning sign of potential progression to hypertension, which ...
EuTYPH-C Inj.® Multi-dose demonstrates strong safety and immunogenicity: Results now available from a Phase 3 study
2025-11-13
Seattle, United States & Seoul, Republic of Korea—PATH and EuBiologics Co., LTD are pleased to announce Phase 3 results from a clinical trial of a typhoid conjugate vaccine (TCV), EuTYPH-C Inj.® Multi-dose. EuTYPH-C Inj.® Multi-dose is manufactured by EuBiologics Co., LTD, Republic of Korea. The results, published in The Lancet Global Health, demonstrate that EuTYPH-C Inj.® Multi-dose is safe and immunogenic in typhoid-endemic populations in sub-Saharan Africa.
The study was conducted at sites in Kenya and Senegal in healthy ...
Fossil fuel CO2 emissions hit record high in 2025
2025-11-13
Global carbon emissions from fossil fuels are projected to rise by 1.1% in 2025 – reaching a record high, according to new research by the Global Carbon Project.
The 2025 Global Carbon Budget projects 38.1 billion tonnes of fossil carbon dioxide (CO2) emissions this year.
Decarbonisation of energy systems is progressing in many countries – but this is not enough to offset the growth in global energy demand.
With projected emissions from land-use change (such as deforestation) down to 4.1 billion ...
Bold action needed to fix NHS clinical placement crisis
2025-11-13
A fundamental rethink of how the NHS trains its future workforce is urgently needed, according to a new paper from the Higher Education Policy Institute (www.hepi.ac.uk), Rethinking Placement: Increasing Clinical Placement Efficacy for a Sustainable NHS Future (HEPI Report 194).
The paper, written by senior leaders from the University of East London (UEL), argues that the National Health Service (NHS) cannot achieve its ambitious workforce goals without bold system-wide reform of how students gain real-world experience – the essential bridge between classroom learning and frontline care.
The HEPI Report, which has been published with the support of the Council for Deans ...
Six strategies to reinvigorate the doctor-patient bedside encounter
2025-11-12
Most commonly reported error in the physical exam is that the exam was never performed
Report in the New England Journal of Medicine is part of a six-issue series on medical education
‘If we don’t intentionally cultivate these bedside skills, they’re at risk of being lost’
CHICAGO --- Today’s doctor visits look and feel a lot different than they did even just a couple decades ago.
Rushed physicians and medical trainees are spending less time with patients, leading to diagnostic errors, ...
Mount Sinai study reveals why some myeloma patients stay cancer-free for years after CAR T therapy
2025-11-12
New York, NY (November 12, 2025) – A new study from the Icahn School of Medicine at Mount Sinai helps explain why some people with multiple myeloma, a type of blood cancer, stay in remission for many years after receiving CAR T cell therapy, while others see their cancer return sooner.
Published in Blood Advances, the research is the first longitudinal, single-cell, multi-omic study of cilta-cel in multiple myeloma. Cilta-cel (ciltacabtagene autoleucel) is a type of CAR T cell therapy used to treat relapsed or refractory multiple myeloma. It works ...
How climate change brings wildlife to the yard
2025-11-12
As climate change increases the frequency of droughts, UCLA and UC Davis researchers found one overlooked side effect: People report more conflicts with wildlife during drought, when resources are scarce.
For every inch that annual rainfall decreases, scientists found a 2% to 3% increase in reported clashes with a variety of carnivores during drought years, according to a paper published today, Nov. 12, in the journal Science Advances.
The researchers pored through seven years of data from the Wildlife Incident Reporting database, run by the California Department of Fish and Wildlife. The results are likely broadly applicable outside of California, said lead author Kendall Calhoun, ...
Plants balance adaptability in skin cells with stability in sex cells
2025-11-12
Mutations drive evolution, but they can also be risky. New research led by plant biologists at the University of California, Davis, published Nov. 10 in Proceedings of the National Academy of Sciences, reveals how plants control mutation rates in different stem cells to balance adaptability with safety and stability. The findings have implications for breeding some of the world’s most important fruit and vegetable crops, such as potatoes and bananas.
The researchers showed that DNA mutations accumulated up to 4.5 times more frequently in the stem cells that produce a plant’s ...